Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia

Authors: Rebecca Anderson, Lance D. Miller, Scott Isom, Jeff W. Chou, Kristin M. Pladna, Nathaniel J. Schramm, Leslie R. Ellis, Dianna S. Howard, Rupali R. Bhave, Megan Manuel, Sarah Dralle, Susan Lyerly, Bayard L. Powell, Timothy S. Pardee

Source: Nature Communications, Vol 13, Iss 1, Pp 1-13 (2022)

Subject Terms: Science

File Description: electronic resource

Relation: https://doaj.org/toc/2041-1723

Access URL: https://doaj.org/article/af7e039587ff405b8de70ccdba887ce2

The prognostic value of standardized phase angle in adults with acute leukemia: A prospective study

Authors: Samuel J. Yates, Susan Lyerly, Megan Manuel, Janet A. Tooze, Heidi D. Klepin, Bayard L. Powell, Sarah Dralle, Alok Uprety, Timothy S. Pardee

Source: Cancer Medicine, Vol 9, Iss 7, Pp 2403-2413 (2020)

Subject Terms: body composition, leukemia, nutrition, phase angle, prognostic, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2045-7634

Access URL: https://doaj.org/article/b87ea54ff8ec472aa131fd5bd10a77ec

The Novel Phospholipid Mimetic KPC34 Is Highly Active Against Acute Myeloid Leukemia with Activated Protein Kinase C

Authors: Peter M. Alexander, Gregory L. Kucera, Kristin M. Pladna, Timothy S. Pardee

Source: Translational Oncology, Vol 13, Iss 7, Pp 100780- (2020)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S1936523320300279; https://doaj.org/toc/1936-5233

Access URL: https://doaj.org/article/ee4e4655a9e24c83aa6cad36ad767c7a

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

The novel phospholipid mimetic KPC34 is highly active against preclinical models of Philadelphia chromosome positive acute lymphoblastic leukemia.

Authors: Peter M Alexander, David L Caudell, Gregory L Kucera, Kristin M Pladna, Timothy S Pardee

Source: PLoS ONE, Vol 12, Iss 6, p e0179798 (2017)

Subject Terms: Medicine, Science

File Description: electronic resource

Relation: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0179798&type=printable; https://doaj.org/toc/1932-6203

Access URL: https://doaj.org/article/fbc92f395c0547b2b1be435dfb9d602f

A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma.

Authors: Thomas W Lycan, Timothy S Pardee, William J Petty, Marcelo Bonomi, Angela Alistar, Zanetta S Lamar, Scott Isom, Michael D Chan, Antonius A Miller, Jimmy Ruiz

Source: PLoS ONE, Vol 11, Iss 10, p e0164244 (2016)

Subject Terms: Medicine, Science

File Description: electronic resource

Relation: http://europepmc.org/articles/PMC5061374?pdf=render; https://doaj.org/toc/1932-6203

Access URL: https://doaj.org/article/54e819e4ead94f18a11e281914d91edf

The efficacy of the ribonucleotide reductase inhibitor Didox in preclinical models of AML.

Authors: Guerry J Cook, David L Caudell, Howard L Elford, Timothy S Pardee

Source: PLoS ONE, Vol 9, Iss 11, p e112619 (2014)

Subject Terms: Medicine, Science

File Description: electronic resource

Relation: http://europepmc.org/articles/PMC4234372?pdf=render; https://doaj.org/toc/1932-6203

Access URL: https://doaj.org/article/a01e79b4a2e148b59d1b9f147df0cd51

Overexpression of MN1 confers resistance to chemotherapy, accelerates leukemia onset, and suppresses p53 and Bim induction.

Authors: Timothy S Pardee

Source: PLoS ONE, Vol 7, Iss 8, p e43185 (2012)

Subject Terms: Medicine, Science

File Description: electronic resource

Relation: http://europepmc.org/articles/PMC3419213?pdf=render; https://doaj.org/toc/1932-6203

Access URL: https://doaj.org/article/c59b7f65501a4bd1b7ac22bcbab68bef